STAT January 11, 2022
Over the last year, Katie dove into the science and business of continuous glucose monitors. For a comprehensive look at what’s ahead for the devices — not just for diabetes patients, but the broader public — grab a copy of our new STAT Report.
Biosensors at three-letter conferences
Speaking of CGM, device maker Dexcom’s presentation at this week’s all-virtual JP Morgan Healthcare Conference finally showed forward movement on its next-generation continuous glucose monitor, the G7. The company filed with the FDA in late 2021, and shared data from its submission at JPM, including results showing that the device meets the standards to feed its data into automated insulin pumps. “Our current systems have been designed to readily connect with the...
Today's Sponsors
Today's Sponsor